Related Experiment Video

Updated: Feb 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease

Gerard M London

    Blood Purification
    |February 26, 2018
    PubMed

    Insights

    Patients with chronic kidney disease (CKD) experience accelerated aging, specifically premature vascular aging and arterial stiffening. This condition significantly increases risks for cardiovascular issues and mortality.

    Area of Science:

    • Nephrology
    • Cardiology
    • Gerontology

    Background:

    • Chronic kidney disease (CKD) is linked to accelerated aging, termed
    • progeria
    • in patients.
    • Premature vascular aging and arterial stiffening are key features, evident even in early CKD stages.

    Purpose of the Study:

    • To investigate the link between chronic kidney disease and accelerated vascular aging.
    • To understand the implications of arterial stiffening in CKD patients.

    Main Methods:

    • The study focuses on observational data regarding arterial properties in CKD patients.
    • Analysis of vascular aging markers and arterial stiffness in relation to CKD progression.

    Main Results:

    • Accelerated aging and arterial stiffening are prominent in CKD patients.
    • Aortic stiffening correlates with adverse cardiovascular outcomes, including mortality and morbidity.
    • Arterial stiffness gradient changes in CKD impact microcirculation protection.

    Conclusions:

    • CKD significantly accelerates vascular aging, leading to arterial stiffening.
    • Systemic microinflammation and vascular calcification are key contributors to arterial stiffening in CKD.
    • Arterial stiffening in CKD is a critical predictor of cardiovascular events and mortality.

    Keywords:
    AgingArterial stiffnessInflammationMicrocirculation

    More Related Videos

    Direct Drug Delivery to Kidney via the Renal Artery11:18

    Direct Drug Delivery to Kidney via the Renal Artery

    Published on: April 17, 2021

    8.3K
    5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat08:50

    5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

    Published on: July 3, 2013

    24.4K

    Related Concept Videos

    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    768
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    688
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    485
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
    416
    Chronic Obstructive Pulmonary Disease01:24

    Chronic Obstructive Pulmonary Disease

    COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
    Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
    2.6K
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    1.2K